GluN2A inhibitor(Topia Life Sciences)

N/A

Report date: 2025/12/31 17:56:55

NME

Base Information

Drug NameGluN2A inhibitor(Topia Life Sciences)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionGlutamate receptor ionotropic, NMDA 2A inhibitors

TargetsGlutamate receptor ionotropic, NMDA 2A

Therapy Area/IndicationsAnxiety DisordersStress, Psychological

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTopia Life Sciences

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsAnxiety DisordersStress, Psychological

Inactive IndicationsN/A

ATC CodeN/A